These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

403 related articles for article (PubMed ID: 23375740)

  • 21. Variations in the cytomegalovirus DNA polymerase and phosphotransferase genes in relation to foscarnet and ganciclovir sensitivity.
    Mousavi-Jazi M; Schloss L; Drew WL; Linde A; Miner RC; Harmenberg J; Wahren B; Brytting M
    J Clin Virol; 2001 Dec; 23(1-2):1-15. PubMed ID: 11595579
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Drug-resistant cytomegalovirus in transplant recipients: a French cohort study.
    Hantz S; Garnier-Geoffroy F; Mazeron MC; Garrigue I; Merville P; Mengelle C; Rostaing L; Saint Marcoux F; Essig M; Rerolle JP; Cotin S; Germi R; Pillet S; Lebranchu Y; Turlure P; Alain S;
    J Antimicrob Chemother; 2010 Dec; 65(12):2628-40. PubMed ID: 20961907
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The impact of drug-resistant cytomegalovirus in pediatric allogeneic hematopoietic cell transplant recipients: a prospective monitoring of UL97 and UL54 gene mutations.
    Choi SH; Hwang JY; Park KS; Kim Y; Lee SH; Yoo KH; Kang ES; Ahn JH; Sung KW; Koo HH; Kim YJ
    Transpl Infect Dis; 2014 Dec; 16(6):919-29. PubMed ID: 25405808
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mass spectrometry-based comparative sequencing to detect ganciclovir resistance in the UL97 gene of human cytomegalovirus.
    Posthuma CC; van der Beek MT; van der Blij-de Brouwer CS; van der Heiden PL; Marijt EW; Spaan WJ; Claas EC; Nederstigt C; Vossen AC; Snijder EJ; Kroes AC
    J Clin Virol; 2011 May; 51(1):25-30. PubMed ID: 21388868
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Rapid detection by reverse hybridization of mutations in the UL97 gene of human cytomegalovirus conferring resistance to ganciclovir.
    Zhou L; Harder TC; Ullmann U; Rautenberg P
    J Clin Virol; 1999 Jun; 13(1-2):53-9. PubMed ID: 10405892
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A deletion at CMV UL54 codon 524 without co-existing resistance-associated mutation at UL97 confers resistance to ganciclovir: A case report.
    Green CB; O'Riordan A; Griffiths P; Haque T
    J Clin Virol; 2016 Jul; 80():24-6. PubMed ID: 27131599
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Dynamics of cytomegalovirus populations harbouring mutations in genes UL54 and UL97 in a haematopoietic stem cell transplant recipient.
    Schnepf N; Dhédin N; Mercier-Delarue S; Andreoli A; Mamez AC; Ferry C; Deback C; Ribaud P; Robin M; Socié G; Simon F; Mazeron MC
    J Clin Virol; 2013 Dec; 58(4):733-6. PubMed ID: 24183928
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diversity of antiviral-resistant human cytomegalovirus in heart and lung transplant recipients.
    Iwasenko JM; Scott GM; Naing Z; Glanville AR; Rawlinson WD
    Transpl Infect Dis; 2011 Apr; 13(2):145-53. PubMed ID: 21070537
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Sequence analysis of UL54 and UL97 genes and evaluation of antiviral susceptibility of human cytomegalovirus isolates obtained from kidney allograft recipients before and after treatment.
    Mousavi-Jazi M; Hökeberg I; Schloss L; Zweygberg-Wirgart B; Grillner L; Linde A; Brytting M
    Transpl Infect Dis; 2001 Dec; 3(4):195-202. PubMed ID: 11844151
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Analysis of cytomegalovirus DNA polymerase (UL54) mutations in solid organ transplant patients receiving valganciclovir or ganciclovir prophylaxis.
    Boivin G; Goyette N; Gilbert C; Covington E
    J Med Virol; 2005 Nov; 77(3):425-9. PubMed ID: 16173018
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Molecular Analysis of Ganciclovir-Resistant Cytomegalovirus in Renal Transplant Recipients with High Viral Load.
    Sohrabi M; Behzadian F; Hosseini SM; Lashini H
    Arch Iran Med; 2016 Oct; 19(10):700-703. PubMed ID: 27743434
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Molecular Epidemiology of Cytomegalovirus UL97 and UL54 variants in Taiwan.
    Yang SL; Lin TW; Lin HC; Wang HY; Chang PY; Wang PN; Yang S; Lu JJ
    J Microbiol Immunol Infect; 2021 Oct; 54(5):971-978. PubMed ID: 33632621
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development of new cytomegalovirus UL97 and DNA polymerase mutations conferring drug resistance after valganciclovir therapy in allogeneic stem cell recipients.
    Marfori JE; Exner MM; Marousek GI; Chou S; Drew WL
    J Clin Virol; 2007 Feb; 38(2):120-5. PubMed ID: 17157554
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cytomegalovirus resistance in solid organ transplant recipients treated with intravenous ganciclovir or oral valganciclovir.
    Boivin G; Goyette N; Rollag H; Jardine AG; Pescovitz MD; Asberg A; Ives J; Hartmann A; Humar A
    Antivir Ther; 2009; 14(5):697-704. PubMed ID: 19704173
    [TBL] [Abstract][Full Text] [Related]  

  • 35. A point mutation in the human cytomegalovirus DNA polymerase gene selected in vitro by cidofovir confers a slow replication phenotype in cell culture.
    Cihlar T; Fuller MD; Mulato AS; Cherrington JM
    Virology; 1998 Sep; 248(2):382-93. PubMed ID: 9721246
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Clinical and biologic aspects of human cytomegalovirus resistance to antiviral drugs.
    Baldanti F; Lurain N; Gerna G
    Hum Immunol; 2004 May; 65(5):403-9. PubMed ID: 15172438
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Drug susceptibility and UL97 gene mutation analysis of cytomegalovirus in recipients of hematopoietic stem cell transplantation].
    Zeng A; Dong D; Cui X; Guo M; Zou D; Fang J
    Nan Fang Yi Ke Da Xue Xue Bao; 2014 Apr; 34(4):519-22. PubMed ID: 24752100
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antiviral Drug- and Multidrug Resistance in Cytomegalovirus Infected SCT Patients.
    Göhring K; Hamprecht K; Jahn G
    Comput Struct Biotechnol J; 2015; 13():153-9. PubMed ID: 25750703
    [TBL] [Abstract][Full Text] [Related]  

  • 39. New reporter cell line to evaluate the sequential emergence of multiple human cytomegalovirus mutations during in vitro drug exposure.
    Gilbert C; Boivin G
    Antimicrob Agents Chemother; 2005 Dec; 49(12):4860-6. PubMed ID: 16304146
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Detecting human cytomegalovirus drug resistant mutations and monitoring the emergence of resistant strains using real-time PCR.
    Volfova P; Lengerova M; Lochmanova J; Dvorakova D; Ricna D; Palackova M; Weinbergerova B; Mayer J; Racil Z
    J Clin Virol; 2014 Oct; 61(2):270-4. PubMed ID: 25130511
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 21.